DNAprint Genomics (DNAG)

[frogdreaming]

Bag8ger, You can't be serious.

frog, I read the post, the answer was not there.


here is the post:
frog,

You said:

"The new EPO drug for instance has no real connection to personalized medicine as it is expected to compete in the same markets with the existing 'non-personalized' versions."

I must have given the wrong understanding to "has no real connection to personalized medicine."

Did you mean, currently has no connection?

What is a 'real' connection?


The answer is; The new EPO drug not only does not yet exist, but it is not personalized. Any assumptions that it will be personalized are just that, assumptions. I repeat "there is no real connection".

Here is the relevant part of the post you responded to;

Try these simple facts.

A drug cannot be personalized until it exists. (The new EPO does not yet exist as a drug. It is a development compound based on theoretical analysis that has been created on a lab bench and undergone some chemical evaluation and may have been tested on lab animals.)

A drug cannot be personalized until it has been tested on patients (in a controlled environment) AND provided some variability in effectivity. (If it works the same for everyone, it cannot be personalized.)

A drug cannot be given to human patients UNTIL it has satisfied several regulatory performance requirements, including animal testing for safety.

So far so good?

Given the current state of the new EPO development, the following facts are self evident;

It has not been personalized.

It has not been shown to be 'personalize-able'. (I made that word up.)

To suggest that it 'will' be personalized in the future makes a number of unwarranted assumptions and is wishful thinking.

regards,
frog